Indefinite Delivery Contract HHSO100201200012I

This federal contract IDV award was issued by the Centers for Disease Control and Prevention (CDC) to procure pediatric vaccines for the Vaccines for Children (VFC) program. The 5-year, $1.35 billion multiple award contract aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The prime contractor,...

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...

The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to The American National Red Cross, doing business as American Red Cross, a major supplier of blood and blood products to the federal government. The $331,324.59 contract, which is not set aside, has an ultimate completion date of November 30, 2026. Under this IDC, the American Red Cross will provide critical blood products, including whole blood, blood components, and specialized laboratory services,...

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support military medical facilities worldwide. The IDC, valued up to $499,999,999, allows DLA to issue firm fixed-price delivery orders for common medications like antibiotics and cardiovascular drugs, as well as specialized...

The National Prime Vendor contract will provide pharmaceutical products and related services to multiple TRICARE Mail Order Pharmacy and TRICARE Specialty Pharmacy Network ordering facilities in support of the Defense Health Agency's TRICARE Pharmacy Program. Amerisourcebergen Drug Corporation will serve as the prime vendor, delivering products from distribution centers including a location in Conshohocken, Pennsylvania. Delivery orders issued against the contract, valued at amounts ranging...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA), provides a wide range of pharmaceutical and hematology-related products to support the healthcare missions of various federal agencies, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The prime contractor, DR Reddy's Laboratories, Inc., a multinational pharmaceutical company, holds a 5-year FSS contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB)...

The federal contract IDV awarded to Amgen USA Inc., a division of the biotechnology company Amgen Inc., is primarily focused on supplying calcitonin gene-related peptide (CGRP) agents to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The original solicitation, RFP 36E79719R0025 issued by the VA National Acquisition Center, sought a one-year contract with four one-year option periods to provide Erenumab-aooe, Fremanezumab-vfrm, and...

This federal contract IDV award is for the supply of ranibizumab ophthalmic injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award indefinite delivery contract, valued at $11,392,063.40, was issued by the VA National Acquisition Center to the prime contractor Biogen U.S. Corporation, a for-profit pharmaceutical manufacturer. The contract has a performance period from December 23, 2023, through December 22, 2025, with...

The U.S. Department of Veterans Affairs (VA) has awarded a multiple-award Federal Supply Schedule (FSS) contract to Kyowa Kirin, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the procurement of "Drugs, Pharmaceuticals, & Hematology Related Products." The contract has a ceiling value of $17,788,800 and a period of performance through September 29, 2027. In addition to the FSS contract, the VA's National Acquisition Center has awarded a single-award Blanket...